MK-677 GW-501516
Growth Edge is a research chemical blend combining MK-677 and Cardarine (GW-501516). Although often categorized as SARMs, these compounds are not technically selective androgen receptor modulators.
Ingredients and Dosage:
Ibutamoren (MK-677) is known for its ability to sustain the activation of the GH–IGF-1 axis, thereby increasing lean body mass without affecting total fat mass or visceral fat. This compound is being investigated as a potential treatment for conditions with reduced hormone levels, such as growth hormone deficiency in children or elderly adults. Human studies have demonstrated that ibutamoren can increase both muscle mass and bone mineral density, suggesting it as a promising therapy for treating frailty in the elderly. As of June 2017, ibutamoren remains in the preclinical stage of development for addressing growth hormone deficiency.
GW501516 (Cardarine), also known by various names including GW-501,516, GW1516, GSK-516, Cardarine, and Endurobol, is a PPARδ receptor agonist. It was developed in the 1990s through a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline. Cardarine entered clinical development as a potential treatment for metabolic and cardiovascular diseases.